Skip to content

A Phase 1 study of a novel sublingual insulin formulation

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-521863-11-00
Enrollment
19
Registered
2026-09-04
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 diabetes mellitus

Interventions

None listed

Sponsors

Sublin B.V.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
Male
Age
18 Years to 64 Years

Outcome results

None listed

Source: EU CTIS · Data processed: Sep 5, 2026